Molecular features of traditional Chinese medicine syndrome evolution in chronic liver diseases: a dynamic network biomarker analysis

医学 中医药 生物标志物 精密医学 生物信息学 疾病 计算生物学 内科学 梅德林 汉族 肿瘤科 临床实习 病理
作者
Chen Qingqing,Zhang Hua,Guo Dong,Cai Hong,Lu Yiyu
出处
期刊:Digital Chinese medicine [Elsevier BV]
卷期号:9 (2): 241-256 被引量:1
标识
DOI:10.1016/j.dcmed.2026.05.005
摘要

Objective To elucidate the biological basis of traditional Chinese medicine (TCM) syndromes from the perspective of “same syndrome, different diseases” in patients with chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC), thereby providing a complementary approach for the diagnosis and treatment of chronic liver diseases (CLD). Methods To investigate the dynamic characteristics of TCM syndromes in CLD, transcriptomic profiling of peripheral blood mononuclear cells (PBMCs) was performed from patients with CHB, LC, or HCC presenting with three TCM syndromes: liver gallbladder dampness heat syndrome (LGDHS), liver depression spleen deficiency syndrome (LDSDS), and liver kidney Yin deficiency syndrome (LKYDS). These participants were recruited at Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine between August 1, 2018 and December 31, 2021. Differentially expressed genes (DEGs) were identified using the random variance model (RVM) F test with false discovery rate (FDR) correction. Principal component analysis (PCA) and unsupervised hierarchical clustering were applied to visualize sample grouping. Dynamic network biomarkers (DNB) analysis was employed to detect critical transition stages during syndrome evolution, followed by Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses to characterize the functional roles and pathway involvement of the DNB members. Random forest (RF) analysis and the area under the receiver operating characteristic (ROC) curves (AUC) were used to rank the importance of candidate genes. External validation was performed using microarray data from an independent CLD cohort (GSE89377) and RNA-seq data from The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) dataset. Additionally, reverse transcription quantitative polymerase chain reaction (RT-qPCR) was performed on an independent cohort of LC patients to validate the expression levels of the candidate genes. Results The study included a total of 132 participants. DNB analysis identified LDSDS stage as a critical tipping point during TCM syndrome evolution across CHB, LC, and HCC. The phosphoinositide 3-kinase/protein kinase B (PI3K-AKT) signaling pathway was consistently enriched in the DNB analysis across all three types of CLD, suggesting its potential involvement in the critical transition of TCM syndromes. Among the 24 core DNB members of the PI3K-AKT pathway, four genes—integrin subunit beta 1 ( ITGB1 ), collagen type IV alpha 1 chain ( COL4A1 ), collagen type IV alpha 2 chain ( COL4A2 ), and DNA damage inducible transcript 3 ( DDIT3 )—were identified by RF analysis (Gini score > 1) and ROC analysis. ROC analysis demonstrated high discriminative ability for distinguishing LGDHS from LKYDS in CHB patients, with AUC of 0.7891 for ITGB1 , 0.7070 for COL4A1 , 0.7148 for COL4A2 , and 0.8945 for DDIT3 . In the independent CLD cohort (GSE89377), all four genes showed significant stepwise upregulation from normal to CHB, LC, and HCC (all P < 0.05). In the TCGA-LIHC dataset, their expression progressively increased with tumor stage. RT-qPCR validation in an independent LC cohort (30 LGDHS vs. 30 LKYDS) confirmed that ITGB1 , COL4A2 , and DDIT3 were significantly upregulated in LKYDS compared with LGDHS ( P = 0.0152, 0.0186, and 0.0247, respectively), whereas COL4A1 showed a non-significant upward trend ( P = 0.1201). Conclusion This study introduces a novel approach to understanding the molecular features underlying TCM syndrome evolution in CLD. The PI3K-AKT pathway and four identified genes ( ITGB1 , COL4A1 , COL4A2 , and DDIT3 ) play crucial roles in the transition from excess (LGDHS) to deficiency (LKYDS) via the critical LDSDS stage. These findings offer potential quantitative biomarkers and therapeutic targets for TCM syndrome differentiation and may help arrest syndrome progression in CLD.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
东方元语发布了新的文献求助10
1秒前
moonlight发布了新的文献求助10
1秒前
1秒前
文艺代灵发布了新的文献求助10
3秒前
3秒前
3秒前
zhk完成签到,获得积分10
3秒前
浮云发布了新的文献求助10
3秒前
AXX041795发布了新的文献求助10
4秒前
洋洋得意发布了新的文献求助10
4秒前
哈弟完成签到,获得积分10
4秒前
徐诚发布了新的文献求助10
5秒前
xiamumu完成签到,获得积分10
5秒前
海鲜面完成签到,获得积分10
6秒前
buta发布了新的文献求助10
7秒前
7秒前
8秒前
8秒前
彭于晏完成签到 ,获得积分10
8秒前
10秒前
隐形曼青的应助被徐诚采纳,获得10
11秒前
Ava的应助被haan采纳,获得30
11秒前
12秒前
12秒前
tot完成签到 ,获得积分10
12秒前
jajai完成签到,获得积分10
12秒前
younger发布了新的文献求助10
13秒前
做猪要开心完成签到,获得积分10
14秒前
14秒前
Carrie发布了新的文献求助10
14秒前
FashionBoy的应助被馒头就辣条采纳,获得10
15秒前
liu关闭了liu的文献求助
15秒前
一叶完成签到 ,获得积分10
16秒前
16秒前
打打的应助被晚风采纳,获得10
16秒前
华仔的应助被爱听歌的寄云采纳,获得10
17秒前
17秒前
17秒前
17秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178807
求助须知:如何正确求助?哪些是违规求助? 9569558
关于积分的说明 21805222
捐赠科研通 7773974
什么是DOI,文献DOI怎么找? 3432933
关于科研通互助平台的介绍 2556873
邀请新用户注册赠送积分活动 2478593